As a pharmaceutical company headquartered in Zurich, Switzerland, we develop, manufacture and internationally market well-proven and innovative pharmaceuticals in novel drug delivery forms.
We are proudly known for the quality of products, people, and service.
We are a leader in advanced drug delivery technologies with a focus on modified release and dispersible forms, for which we also hold patents.
We have a bold ambition
- To stand out in the world of pharma
- To be proudly different
- To have a human face, not a corporate face
And we have a clear purpose for both B2C and B2B parts of the business
- B2C: to make high-quality medicines accessible to patients and healthcare professionals in emerging markets
- B2B: to be the preferred high-quality contract manufacturing and out-licensing partner
for full-year 2022
Sales % in emerging markets
as of end of 2022
Switzerland (2), Ukraine, Estonia, United Arab Emirates and South Africa
Dubai, Kyiv, Johannesburg, Moscow and Panama City